Blockbuster Weight-Loss Drug Linked to Serious Kidney Issues
Joseph Mercola Semaglutide, the blockbuster drug being used for weight loss, is slated to bring in more than $10 billion in annual sales but serious adverse e!ects are emerging. A study using data from Eudravigilance, Europe’s system for analyzing adverse reactions to medications, found a high prevalence of gastrointestinal disorders among users. Other semaglutide patients […]
Popular Weight-loss Drugs Pose Serious Risks for Pregnant Women – But Warnings are Buried
Brenda Baletti Ozempic and Wegovy, the drugs at the center of the latest weight-loss craze, carry serious and under- discussed risks for pregnant women. The U.S. Food and Drug Administration (FDA) warns that the use of Ozempic — approved for diabetes but taken off-label for weight loss — and Wegovy should be discontinued at least […]
